Health
New insights into participation of underrepresented communities in Alzheimer’s clinical trials – News-Medical.Net
A significant hurdle in developing therapeutics and care models for Alzheimer’s disease that work for people of all ethnic and…
A significant hurdle in developing therapeutics and care models for Alzheimer’s disease that work for people of all ethnic and racial backgrounds is the recruitment and retention of traditionally underrepresented groups in clinical trials. At the Alzheimer’s…
Continue Reading
-
Noosa News11 hours agoSuncorp Stadium upgrades to rival Sydney as seat capacity and infrastructure prioritised
-
General23 hours agoAn open letter to pro-Palestinian protesters
-
Business13 hours agoDroneShield announces new $13 million counter-drone facility as employees top 400
-
General19 hours agoHopes for peace but pain lingers on Oct 7 anniversary